Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Medical Marijuana Got A Major Federal Upgrade

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Schedule I — the most restrictive category, reserved for substances with “no accepted medical use” — is where marijuana has sat since 1970, alongside heroin. Moving to Schedule III, the same category as ketamine and certain anabolic steroids, is a landmark shift that recognizes what 40 U.S. states have already acknowledged for years: medical marijuana has genuine therapeutic value. For patients, the change could improve access and affordability, as medical cannabis businesses will no longer face a punishing tax rule that had effectively prohibited them from deducting standard business expenses, often pushing effective federal tax rates on those businesses as high as 70 to 80 percent.

For scientists, the rescheduling is equally significant. Schedule I status has long created enormous barriers to cannabis research, making it exceptionally difficult to study a substance tens of millions of Americans already use. Researchers studying everything from chronic pain to epilepsy to PTSD have faced federal restrictions that simply don’t apply to other substances under study. Those barriers will now ease meaningfully. A DEA administrative hearing beginning June 29, 2026, will consider whether the rescheduling extends to all marijuana — including recreational products. For now, the immediate and historic win belongs to the patients, doctors, and researchers who have long argued that science, not stigma, should drive federal drug policy.

Source: https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268

PrevPreviousA Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

Recent Articles

Happy News

For The First Time In History 60 Nations Gathered To Discuss Phasing Out Fossil Fuels

April 28, 2026

Something historic is happening right now in the coastal city of Santa Marta, Colombia, where more than 60 nations have gathered for the first international conference ever dedicated entirely to the question of how the world should phase out fossil fuels. The gathering, co-hosted by Colombia and the Netherlands, was

Read More
Happy News

A Runner Broke The Two-Hour Barrier For The First Time Ever

April 27, 2026

Something happened today at the TCS London Marathon that the running world has been chasing for decades. Kenyan runner Sabastian Sawe crossed the finish line in 1:59:30 — making him the first person in history to run a marathon in under two hours under official, record-eligible conditions. That is not

Read More
Happy News

6500 Volunteers Just Built 10000 Beds In A Day For Kids Who Have Never Had One

April 27, 2026

More than 140,000 children across the United States do not have a bed to sleep in, and this week a group of 6,500 volunteers decided to make a serious dent in that number, gathering at the Charlotte Convention Center in North Carolina and building over 10,000 beds in just 24

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.